Best Research Article Award
Dhanya Dharman
Dr Moopens College of Pharmacy, India
Paper Title: Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study
Dhanya Dharman is a researcher affiliated with Dr Moopens College of Pharmacy, India, whose scholarly record includes 53 documents and 37 citations, with a reported h-index of 4. The research profile is situated within pharmacology and includes work examining therapeutic approaches for severe asthma, including single-inhaler triple therapy. [1]
Abstract
Dhanya Dharman is a pharmacology researcher affiliated with Dr Moopens College of Pharmacy in India. Her documented research profile comprises 53 scholarly documents, 37 citations, and an h-index of 4. A relevant research contribution examines the effectiveness of mometasone, indacaterol, and glycopyrronium, administered once daily through a single inhaler, for managing severe asthma. The prospective observational study addresses clinical treatment effectiveness within a real-world patient context and contributes to evidence concerning inhaled corticosteroid, long-acting beta2-agonist, and long-acting muscarinic antagonist combinations. The work reflects an applied pharmacological perspective focused on therapeutic management, treatment response, and respiratory disease care. [1]
Keywords
Severe asthma; triple therapy; mometasone; indacaterol; glycopyrronium; inhaler therapy; pharmacology; respiratory medicine; prospective observational study; asthma management.
Introduction
Severe asthma can require intensified pharmacological management when conventional treatment does not provide adequate control. Inhaled corticosteroids combined with long-acting bronchodilators are established therapeutic approaches, while triple therapy adds a long-acting muscarinic antagonist. The submitted study investigates this combination in a prospective observational setting. [1]
Research Profile
The supplied bibliometric record identifies 53 documents, 37 citations, and an h-index of 4 for Dhanya Dharman. These indicators provide a quantitative description of indexed scholarly output and citation activity, although bibliometric measures should be interpreted alongside publication quality, research context, authorship, and field-specific citation practices. [1]
Research Contributions
The principal research contribution identified for this recognition concerns the prospective observational assessment of once-daily single-inhaler triple therapy containing mometasone, indacaterol, and glycopyrronium. The study focuses on severe asthma management and provides clinical observations relevant to evaluating combined inhaled pharmacotherapy in routine treatment environments. [2]
Publications
The supplied record reports 53 documents associated with the researcher. The specifically identified paper is titled Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study. Complete bibliographic metadata, including journal, publication year, DOI, and author list, was not supplied and should therefore be verified before formal citation. [1]
Research Impact
The reported 37 citations indicate that the research output has received scholarly references in subsequent literature. Citation counts are indicators of academic visibility rather than direct measures of clinical effectiveness or societal benefit. The identified asthma research may be relevant to discussions of inhaled triple therapy and severe respiratory disease management. [1]
Award Suitability
The documented research aligns with the academic scope of a Best Research Article Award through its focus on a defined pharmacological intervention and a clinically relevant respiratory condition. Consideration may include methodological design, clarity of objectives, evidence quality, originality, relevance to pharmacology, and the completeness of supporting publication documentation. [2]
Conclusion
Dhanya Dharman’s supplied research profile documents scholarly activity in pharmacology and includes research addressing severe asthma treatment. The identified prospective observational study examines once-daily single-inhaler triple therapy involving mometasone, indacaterol, and glycopyrronium. Its subject focus provides a relevant basis for academic recognition within pharmacological and respiratory research. [1]
External Links
References
-
- Ramesan, R. (n.d.). Google Scholar profile. Google Scholar.
Google Scholar Profile
-
-